<!-- wp:paragraph -->
<p>COVID 19: SECURITY &amp; PROTECTION CONCERNS<br>In the week that the world started celebrating the news that not one but three experimental vaccines against<br>Covid-19 have proved at least 90% effective at preventing disease in late-stage clinical trials, research into<br>understanding how the Sars-CoV-2 virus, which causes Covid-19, interacts with the human immune system never<br>paused.<br>There are plenty of questions still to answer about the Pfizer/BioNTech and Moderna vaccines and now the<br>Oxford and AstraZeneca and how well they might protect the elderly, for example, and how long for? Which<br>aspects of the immune response that they elicit are protective and which aren’t? Can even better results be<br>achieved, with vaccines that target different parts of the immune system. However, one question that seems to<br>be overlooked by the entire world whilst celebrating, is what security measures are in place to secure the<br>research and development and to stop counterfeit copies that are not as effective or only replicate a % of the real<br>vaccine? It certainly does not seem important for the organisations involved as the research and findings below<br>evidence.<br>On 11th May 2020 Archer, the UK national supercomputing service that was collating Covid-19 research and<br>developments, was breached reportedly by Russia and Chinese state sponsored groups stealing the IP and data.<br>Initially blamed for being targeted to be used for crypto currency mining, the rationale for the attack quickly<br>became clear. $billions in research and developments in Covid-19. Archers homepage became Not Secure,<br>unencrypted with no data integrity several weeks prior to the attack when its digital certificate was allowed to<br>expire. Bizarrely, it remains Not Secure to this day and as a government managed supercomputer, defies all<br>rationale of security and remains a major target.<br>It was also in the weeks leading up to the Archer breach in May that our research discovered Oxford University<br>was maintaining a Not Secure homepage. We continuously informed Oxford University that they were<br>maintaining sub optimal internet facing domains and a homepage that was Not Secure in the same way Archer<br>were. This was ignored for months. Although Oxford did not report a breach at this time, it is important to note</p>
<!-- /wp:paragraph -->

<!-- wp:separator -->
<hr class="wp-block-separator"/>
<!-- /wp:separator -->

<!-- wp:paragraph -->
<p><strong><em><strong><em>__________________________________</em></strong></em></strong> Cybersec Innovation Partners Ltd, 24/25 The Shard, 32 London Bridge Street, London SE1 9SG, United Kingdom.<br>Registered in England and Wales with registration number: 11465050. Registered Office: Linden House, Linden Close,<br>Tunbridge Wells, TN4 8HH. VAT Registration No: GB 302 3877 21<br>they receive £100’s of millions in grants for research and work closely with Archer, as do many of the<br>Pharmaceutical organisations.<br>With the further news of the Covid-19 vaccines we started researching the other Pharmaceutical companies to<br>ensure they were not compromised facing the internet and to our disbelief, when we researched Pfizer. Our<br>research discovered Pfizer are also running sub optimal internet facing domains. We quickly alerted the Board of<br>Pfizer and have yet to receive confirmation or a reply.<br>Our research took us onto Moderna and AstraZeneca. The same situation of negligence of security facing the<br>internet at Moderna and AstraZeneca confirms and shows a worrying systemic security issue that makes one</p>
<!-- /wp:paragraph -->

<!-- wp:separator -->
<hr class="wp-block-separator"/>
<!-- /wp:separator -->

<!-- wp:paragraph -->
<p><strong><em><strong><em>__________________________________</em></strong></em></strong> Cybersec Innovation Partners Ltd, 24/25 The Shard, 32 London Bridge Street, London SE1 9SG, United Kingdom.<br>Registered in England and Wales with registration number: 11465050. Registered Office: Linden House, Linden Close,<br>Tunbridge Wells, TN4 8HH. VAT Registration No: GB 302 3877 21<br>consider, and question the motivation to secure, what could be considered the world’s most incredible<br>development in many generations. Yet at every single organisation, security of IP and data has absolutely no<br>consideration or focus.<br>The pharmaceutical sector is among the very highest of sectors targeted for cyber attacks and a Covid-19<br>vaccine may be the single largest development in modern times. So why is the research and development on<br>vaccines open to cyber attacks and IP theft?</p>
<!-- /wp:paragraph -->